Entera Bio Ltd.

NasdaqCM:ENTX Stock Report

Market Cap: US$79.2m

Entera Bio Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:ENTX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
12 Jan 24BuyUS$9,405Haya TaitelIndividual9,500US$0.99
10 Jan 24BuyUS$5,864Haya TaitelIndividual7,615US$0.77

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ENTX?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders816,9652.22%
Institutions1,441,3493.91%
Public Companies3,732,54010.1%
VC/PE Firms7,931,22821.5%
General Public22,910,13862.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 27.8%.

Top Shareholders

Top 25 shareholders own 37.74% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15%
Knoll Capital Management
5,534,275US$11.9m42.6%9.52%
10.1%
Dna Group (T.R.) Ltd
3,732,540US$8.0m0%no data
6.51%
Centillion Fund, Inc.
2,396,953US$5.2m0%100.0%
1.76%
Schonfeld Strategic Advisors LLC
648,600US$1.4m-3.45%0.01%
1.12%
Parkman Healthcare Partners LLC
411,076US$883.8k2.38%0.12%
0.79%
Gerald Lieberman
290,291US$624.1k4.04%no data
0.39%
UBS Asset Management AG
142,747US$306.9k-14.8%no data
0.35%
Sean Ellis
127,627US$274.4k6.21%no data
0.3%
Miranda Toledano
110,752US$238.1k0%no data
0.17%
Renaissance Technologies LLC
61,200US$131.6k6.25%no data
0.16%
Haya Taitel
57,728US$124.1k14.4%no data
0.15%
Dana Yaacov-Garbeli
56,580US$121.7k0%no data
0.14%
Gregory Burshtein
50,000US$107.5k0%no data
0.13%
Signature Estate & Investment Advisors, LLC
47,328US$101.8k0%no data
0.11%
Yonatan Malca
39,043US$83.9k28.4%no data
0.11%
Gerald Ostrov
38,898US$83.6k27.8%no data
0.093%
Hillel Galitzer
34,106US$73.3k0%no data
0.056%
Susquehanna International Group, LLP, Asset Management Arm
20,658US$44.4k-28.4%no data
0.056%
Citadel Advisors LLC
20,553US$44.2k0%no data
0.048%
Geode Capital Management, LLC
17,597US$37.8k0%no data
0.046%
Osaic Wealth, Inc. , Asset Management Arm
16,777US$36.1k0%no data
0.035%
PNC Financial Services Group Inc., Banking Investments
13,000US$28.0k0%no data
0.034%
Canadian Imperial Bank of Commerce, Asset Management Arm
12,500US$26.9k0%no data
0.032%
HighTower Advisors, LLC
11,830US$25.4k0%no data
0.024%
NewEdge Advisors, LLC
9,000US$19.4k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 23:10
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Entera Bio Ltd. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kalpit PatelB. Riley Securities, Inc.
null nullCG Capital
Raghuram SelvarajuH.C. Wainwright & Co.